


ACTA in a Nutshell –
What is ACTA? ACTA is the Anti-Counterfeiting Trade Agreement. A new intellectual property enforcement treaty being negotiated by the United States, the European Community, Switzerland, and Japan, with Australia, the Republic of Korea, New Zealand, Mexico, Jordan, Morocco, Singapore, the United Arab Emirates, and Canada recently announcing that they will join in as well.
Why should you care about ACTA? Initial reports indicate that the treaty will have a very broad scope and will involve new tools targeting “Internet distribution and information technology.”
What is the goal of ACTA? Reportedly the goal is to create new legal standards of intellectual property enforcement, as well as increased international cooperation, an example of which would be an increase in information sharing between signatory countries’ law enforcement agencies.
Essential ACTA Resources -
- Read more about ACTA here: ACTA Fact Sheet
- Read the authentic version of the ACTA text as of 15 April 2011, as finalized by participating countries here: ACTA Finalized Text
- Follow the history of the treaty’s formation here: ACTA history
- Read letters from U.S. Senator Ron Wyden wherein he challenges the constitutionality of ACTA: Letter 1 | Letter 2 | Read the Administration’s Response to Wyden’s First Letter here: Response
- Watch a short informative video on ACTA: ACTA Video
- Watch a lulzy video on ACTA: Lulzy Video
Say NO to ACTA. It is essential to spread awareness and get the word out on ACTA.
Dude, signal boost the fuck outta this. EVERYONE NEEDS TO KNOW.
Doctors Without Borders report on how ACTA will interfere with access to life-saving medications
ACTA is part of the enforcement agenda advanced by rich countries outside of multilateral normsetting institutions. ACTA would impose limits on price-reducing generic competition and jeopardize the free flow of legitimate medicines across borders. These enforcement efforts enhance the rights of pharmaceutical companies at the expense of poor patients.
…
ACTA has been negotiated in secret with little room for public engagement. Despite its anticipated far-reaching effects, over three years of secret negotiations, an official version of the negotiation text was only released once in April 2010, after the text was leaked and the European Parliament criticized the secret negotiations. The near-final text has now been released and it is TRIPS-plus and does not respect the rights of developing countries to protect the health of their populations and ensure access to medicines.
(via secondside)